ERICH1

Across TCGA pan-cancer cohorts, ERICH1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ERICH1 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ERICH1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ERICH1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PDAC show a favorable association.

HNSC, PDAC, and LSCC are the cancer types where ERICH1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.836	0.584	.006	17	view →
PDAC	OS	Quartile	All	1.000	0.671	<.001	13	view →
LSCC	DFS	Median	II,III,IV	0.912	0.664	.025	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ERICH1–HNSC (OS)

Open the HNSC breakdown →